title: Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer.
abstract: Global transcript analysis is increasingly used to describe cancer taxonomies beyond the microscopic reach of the eye. Diagnostic and prognostic portraits are formulated by ranking cancers according to transcriptional proximity. However, the role that distinct biological factors play in defining these portraits remains undefined. It is likely that the transcriptional repertoire of cancers depends, on one hand, on the anamnestic retention of their ontogenesis and, on the other, on the emergence of novel expression patterns related to oncogenesis. We compared the transcriptional profile of primary renal cell cancers (RCCs) with that of normal kidney tissue and several epithelial cancers of nonrenal origin to weigh the contribution that ontogeny and oncogenesis make in molding their genetic profile. Unsupervised global transcript analysis demonstrated that RCCs retain transcriptional signatures related to their ontogeny and cluster close to normal renal epithelium. When renal lineage-associated genes are removed from the analysis and cancer-specific genes are analyzed, RCCs segregate with other cancers with limited lineage specificity underlying a predominance of the oncogenic process over lineage specificity. However, a RCC-specific set of oncogenesis-related genes was identified and surprisingly shared by sarcomas. In summary, the transcriptional portrait of primary RCCs is largely dominated by ontogeny. Genes responsible for lineage specificity may represent poor molecular targets for immune or drug therapy. Most genes associated with oncogenesis are shared with other cancers and may represent better therapeutic targets. Finally, a small subset of genes is associated with lineage-specific oncogenesis, and these may provide information regarding the biological behavior of RCCs and facilitate diagnostic classification of RCCs.
authors.affiliation: Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Ena
authors.initials: E
authors.lastname: Wang
authors.forename: Rudolf
authors.initials: R
authors.lastname: Lichtenfels
authors.forename: Jurgen
authors.initials: J
authors.lastname: Bükur
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Ngalame
authors.forename: Monica C
authors.initials: MC
authors.lastname: Panelli
authors.forename: Barbara
authors.initials: B
authors.lastname: Seliger
authors.forename: Francesco M
authors.initials: FM
authors.lastname: Marincola
mesh_terms: D018262:Adenocarcinoma, Clear Cell / Q000201:enzymology / Q000235:genetics / Q000378:metabolism; D002256:Carbonic Anhydrases / Q000096:biosynthesis / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D018450:Disease Progression; D020869:Gene Expression Profiling; D005982:Glutathione Transferase / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D007680:Kidney Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000378:metabolism; D008545:Melanoma / Q000235:genetics / Q000378:metabolism; D005810:Multigene Family; D011379:Prognosis; D012509:Sarcoma / Q000235:genetics / Q000378:metabolism; D014158:Transcription, Genetic
chemical_list: D005982:Glutathione Transferase; D002256:Carbonic Anhydrases